One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v124.21.714.714
Copy DOI Journal: Blood |  Publication Date: Dec 6, 2014 |
 Citations: 4 |
Affiliation: Icahn School of Medicine at Mount Sinai, University of Michigan–Ann Arbor, Princess Margaret Cancer Centre, University of British Columbia, Vanderbilt University Medical Center, University of California, Los Angeles, Monash University, Emory University, Incyte (United States), The University of Texas MD Anderson Cancer CenterPrimary Analysis Results from an Open-Label Phase II Study of INCB039110, a Selective JAK1 Inhibitor, in Patients with Myelofibrosis
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
